In patients with HFmrEF/HFpEF, finerenone reduces composite of CV death or total HF events
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
Jessica Schubert, MD
- ESC Congress 2024
New ESC Guidelines for CCS and PAAD
Pierre Sabouret, MD, PhD
- ESC Congress 2024
Beneficial effects of MRAs in HF across the LVEF spectrum
Pardeep Jhund, MD, PhD
- ESC Congress 2024
Continuation or interruption of OAC during TAVI?
Dirk Jan van Ginkel, MD